|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest earned on cash and marketable securities held in Trust Account | |
| Expenses incurred in relation to Forward Purchase Agreement and Class B ordinary shares issued | |
| Expenses incurred for the fair value of warrants exceeding the purchase price | |
| Warrant issuance costs | |
| Unrealized gain on change in fair value of derivative instruments | |
| Changes in assets and liabilities: | |
| Prepaid expenses | |
| Accrued offering costs and expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities | |
| Cash deposited in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds received from initial public offering, net of underwriters' discount | |
| Proceeds from private placement | |
| Payment of offering costs | |
| Repayment of note payable from related party | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, beginning of the period | |
| Cash, end of the period | |
| Supplemental Non-cash disclosure of cash flow information: | |
| Deferred underwriting commissions charged to additional paid in capital | |
| Initial value of ordinary shares subject to possible redemption | |
| Initial classification of warrant liability | |
| Initial classification of FPA Units |
Loading...
